Hypertrophy of the Spinalis Cervicis Muscle in Cervical Dystonia.
[BACKGROUND] Botulinum neurotoxin A (BoNT) is the first line treatment for cervical dystonia (CD) and treatment outcome significantly depends on the correct identification of the muscles involved.
APA
Loens S, Boppel T, Bäumer T (2023). Hypertrophy of the Spinalis Cervicis Muscle in Cervical Dystonia.. Tremor and other hyperkinetic movements (New York, N.Y.), 13, 42. https://doi.org/10.5334/tohm.811
MLA
Loens S, et al.. "Hypertrophy of the Spinalis Cervicis Muscle in Cervical Dystonia.." Tremor and other hyperkinetic movements (New York, N.Y.), vol. 13, 2023, pp. 42.
PMID
37954036
DOI
10.5334/tohm.811
Abstract
[BACKGROUND] Botulinum neurotoxin A (BoNT) is the first line treatment for cervical dystonia (CD) and treatment outcome significantly depends on the correct identification of the muscles involved.
[PHENOMENOLOGY SHOWN] In a case with insufficient response to BoNT treatment further work up with magnetic resonance imaging (MRI) of the neck revealed a hypertrophic spinalis cervicis muscle, that is not commonly involved in CD.
[EDUCATIONAL VALUE] This highlights the use of MRI for muscle selection in treatment refractory CD cases.
[PHENOMENOLOGY SHOWN] In a case with insufficient response to BoNT treatment further work up with magnetic resonance imaging (MRI) of the neck revealed a hypertrophic spinalis cervicis muscle, that is not commonly involved in CD.
[EDUCATIONAL VALUE] This highlights the use of MRI for muscle selection in treatment refractory CD cases.
MeSH Terms
Humans; Torticollis; Botulinum Toxins, Type A; Neck Muscles; Neck; Treatment Outcome